-+ 0.00%
-+ 0.00%
-+ 0.00%

Keybanc Maintains Overweight on Ardent Health, Lowers Price Target to $20

Benzinga·08/07/2025 13:49:05
Listen to the news
Keybanc analyst Matthew Gillmor maintains Ardent Health (NYSE:ARDT) with a Overweight and lowers the price target from $24 to $20.